Cardiac magnetic resonance (CMR) it is a technique without radiation, which is considered the gold-standard for the evaluation of cardiac anatomy, function and even tissue composition. The RESILIENCE trial will use CMR as the main outcome measure methodology, and patients enrolled in the trial will undergo 3 scans across the duration of the study.
Multinational, prospective, proof of concept phase II, double-blinded, sham-controlled, randomized clinical trial (RCT) to evaluate the efficacy and safety of Remote Ischaemic Conditioning (RIC) in Lymphoma patients receiving anthracyclines. Patients scheduled to undergo ≥5 chemotherapy cycles will be eligible.
RESILIENCE grows every day with the incorporation of new centers that expand the network of influence of our project, whose objective is to help people undergoing cancer treatment with anthracyclines to continue their lives with a strong heart. The latest addition has been the Hospital Universitario Virgen de las Nieves in Granada, with whom we […]
